Aristopharma will manufacture some injectable objects, tablets and dry syrups for the listed prescription drugs firm, officers of the 2 corporations instructed The My Information.

The board of administrators of Sq. Prescribed drugs gave go-ahead to the contract manufacturing settlement on July 12 this yr to satisfy elevated demand of its present merchandise and to introduce new merchandise.

Sq. Prescribed drugs shared the data by a posting on the web site of the Dhaka Inventory Change (DSE) yesterday.

Aristopharma is a non-listed firm that began its operations in 1986 and has a state-of-the-art manufacturing plant in Dhaka’s Shampur-Kadamtali.

Yesterday, inventory costs of Sq. Prescribed drugs remained nearly the identical as yesterday and traded at Tk 209 on the DSE.

Throughout July of 2022 to March of 2023, Sq.’s gross sales grew 10 per cent year-on-year to Tk 4,814 crore.